ArticleDermatology and therapy2023

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.

A David Burden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.